Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Letters

A crude approach to evaluating cannabis legalization

Zach Walsh
CMAJ January 28, 2019 191 (4) E109; DOI: https://doi.org/10.1503/cmaj.71177
Zach Walsh
Associate professor, Department of Psychology, University of British Columbia – Okanagan, Kelowna, BC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

The proposal, made by Dr. Kelsall in her recent editorial on cannabis leglization,1 that “any increase in use … be viewed as a failure of this legislation” is flawed. From a methodological perspective, using a single index is blunt and likely to miss the mark. To make matters worse, the criterion of “any increase” is not carefully operationalized. Increased prevalence? Quantity? Frequency? What if one increases while another decreases? Is it a failure if adult use increases while adolescent use decreases?

The principle of harm reduction is recognized by the Canadian Medical Association and countless eminent health organizations. A tenet of harm reduction is that interventions be evaluated for their effects on substance-related harms rather than solely on rates of use. Through quality control, standardization of products and reducing interaction with illegal markets, legalization will likely reduce harms for the millions of Canadian adults who choose to use cannabis. Perhaps more importantly, converging evidence suggests a potential role for cannabis in addressing the opioid epidemic. Would an increase in cannabis use related to substitution for opiods such as fentanyl constitute a legislative failure?

By ignoring harm reduction, the editorial situates itself outside of the mainstream of research on substance use and discourse on drug policy. A plethora of careful reports over the past half century has proposed cannabis legalization in the name of harm reduction. The Canadian health research community has a unique opportunity to carefully test these claims. But we will not get there by simply measuring rates of use. The world is watching. Let’s get it right.

Footnotes

  • Competing interests: Zach Walsh is the lead investigator for academic research studies that are funded in part by Tilray and Doja Cannabis Company (licensed producers of cannabis).

Reference

  1. ↵
    1. Kelsall D
    . Watching Canada’s experiment with legal cannabis. CMAJ 2018;190:E1218.
    OpenUrlFREE Full Text
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 191 (4)
CMAJ
Vol. 191, Issue 4
28 Jan 2019
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A crude approach to evaluating cannabis legalization
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
A crude approach to evaluating cannabis legalization
Zach Walsh
CMAJ Jan 2019, 191 (4) E109; DOI: 10.1503/cmaj.71177

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
A crude approach to evaluating cannabis legalization
Zach Walsh
CMAJ Jan 2019, 191 (4) E109; DOI: 10.1503/cmaj.71177
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Footnotes
    • Reference
  • Responses
  • Metrics
  • PDF

Related Articles

  • Watching Canada’s experiment with legal cannabis
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Hospital-at-home programs in Canada: challenges and pitfalls
  • Author response to “Pitfalls of analyzing perinatal outcomes by health care provider”
  • Pitfalls of analyzing perinatal outcomes by health care provider
Show more Letters

Similar Articles

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

CMA Civility, Accessibility, Privacy

 

Powered by HighWire